Study of Families With Melanoma
NCT00445783 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 3700
Last updated 2013-08-12
Summary
RATIONALE: A study that evaluates patients' lifestyle, skin, and blood and tissue samples may help doctors understand the risk factors for melanoma relapse.
PURPOSE: This clinical trial is studying the risk factors for melanoma in families with melanoma.
Conditions
- Melanoma (Skin)
Interventions
- GENETIC
-
gene expression analysis
- GENETIC
-
mutation analysis
- OTHER
-
immunohistochemistry staining method
- OTHER
-
laboratory biomarker analysis
- PROCEDURE
-
examination
- PROCEDURE
-
mutation carrier screening
- PROCEDURE
-
study of high risk factors
Sponsors & Collaborators
-
Leeds Cancer Centre at St. James's University Hospital
lead OTHER
Principal Investigators
-
Julia Newton Bishop, MD · Leeds Cancer Centre at St. James's University Hospital
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2000-07-31
- Primary Completion
- 2020-12-31
Countries
- United Kingdom
Study Locations
More Related Trials
-
PET and CT Scans to Evaluate Patients With Stage III or Stage IV Melanoma
NCT00004152 ·Status: COMPLETED ·Phase: PHASE2
-
Melanoma Risk Assessment & Tailored Intervention
NCT01356771 ·Status: COMPLETED ·Phase: NA
-
Employment and Quality of Life in Patients With Malignant Melanoma
NCT02668887 ·Status: COMPLETED
-
Utility of Novel BRAF Test for Melanoma
NCT01840527 ·Status: COMPLETED
-
Characteristics of Adult Patients With Melanoma Diagnosis <40 Years Age.
NCT06994208 ·Status: RECRUITING
-
Trial of Pembrolizumab and Radiotherapy in Melanoma
NCT02562625 ·Status: TERMINATED ·Phase: PHASE2
-
Tracing Dissemination of Melanoma Cells in Healthy Tissues
NCT02854124 ·Status: COMPLETED
-
Identification of Risk Factors, Exposomics and Genetic Susceptibility of Melanoma in Children, Adolescents and Young Adults
NCT06680323 ·Status: RECRUITING
-
Investigating Participation Patterns Among Stage IV Melanoma Patients
NCT06093594 ·Status: NOT_YET_RECRUITING
-
A Study to Test the Benefit of a New Anti-cancer Treatment in Patients With Unresectable Advanced Melanoma
NCT00942162 ·Status: COMPLETED ·Phase: PHASE2
-
Investigation of the ROle of faT and inflAmmaTory Cells in mElanoma
NCT07293598 ·Status: NOT_YET_RECRUITING
-
Identification of Metabolic Phenotypes Associated With Melanoma Metastasis
NCT06400550 ·Status: RECRUITING
-
Educational Program in Skin Self-Examination To Detect Melanoma in Healthy Participants
NCT00416988 ·Status: COMPLETED ·Phase: NA
-
Follow-up of a National Cohort of Melanoma Resectable Stage II, Stage III or IV Patients or Unresectable Primary
NCT02828202 ·Status: RECRUITING
-
Head and Neck Melanoma; Access to Staging and Surgical Treatment
NCT05900102 ·Status: COMPLETED
-
Genetic Risk Factors and Acquired Oncogenic Mutations of Melanoma
NCT00849407 ·Status: UNKNOWN
-
Fotemustine in Treating Patients With Metastatic Melanoma
NCT00560118 ·Status: TERMINATED ·Phase: PHASE2
-
Molecularly Targeted Therapy in Treating Patients With BRAF Wild-type Melanoma That is Metastatic
NCT02094872 ·Status: COMPLETED ·Phase: PHASE2
-
Immune Predictors of Response to Pembrolizumab Therapy in Stage IV Melanoma Patients
NCT02744209 ·Status: TERMINATED
-
Study of Molecular Mechanisms Implicated in the Pathogenesis of Melanoma. Role of Exosomes
NCT02310451 ·Status: COMPLETED ·Phase: NA
-
Investigating the Clinical Utility of the MDS
NCT03109327 ·Status: COMPLETED
-
Study of PI-88 in Patients With Advanced Melanoma
NCT00068172 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Study of First-line Treatment Patterns and Clinical Outcomes in Patients With Advanced Melanoma in the United Kingdom
NCT03448497 ·Status: COMPLETED
-
3-month Aerobic and Resistance Exercise Intervention for Individuals Diagnosed With Melanoma
NCT03825913 ·Status: TERMINATED ·Phase: NA
-
A Study to Evaluate the Safety and Efficacy of MGD013 in Patients With Melanoma
NCT04653038 ·Status: TERMINATED ·Phase: PHASE1